Cara Therapeutics (Germany) Today
Cara Therapeutics is selling for under 4.16 as of the 14th of March 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 4.16. Cara Therapeutics has reported 12 for 1 split on 2nd of January 2025. The performance scores are derived for the period starting the 14th of December 2024 and ending today, the 14th of March 2025. Click here to learn more.
Cara Therapeutics Risk Profiles
Although Cara Therapeutics' alpha and beta are two of the key measurements used to evaluate Cara Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.5 | |||
| Semi Deviation | 2.5 | |||
| Standard Deviation | 7.56 | |||
| Variance | 57.09 |
Cara Stock Against Markets
Cara Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cara Therapeutics stock to make a market-neutral strategy. Peer analysis of Cara Therapeutics could also be used in its relative valuation, which is a method of valuing Cara Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Additional Tools for Cara Stock Analysis
When running Cara Therapeutics' price analysis, check to measure Cara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutics is operating at the current time. Most of Cara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutics' price. Additionally, you may evaluate how the addition of Cara Therapeutics to your portfolios can decrease your overall portfolio volatility.